oxazolidin-2-one has been researched along with Respiratory Distress Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batjom, E; Borne, M; Brinquin, L; Cirodde, A; Janvier, F; Libert, N; Nizou, JY | 1 |
Sakai, C; Soda, H | 1 |
Kollef, MH; Shorr, AF; Susla, GM | 1 |
3 other study(ies) available for oxazolidin-2-one and Respiratory Distress Syndrome
Article | Year |
---|---|
[Successful treatment of life-threatening Panton-Valentine leucocidin positive Staphylococcus aureus pneumonia with antibiotics and immunoglobulins targeting the toxin production].
Topics: Acetamides; Adult; Anti-Infective Agents; Bacterial Toxins; Clindamycin; Exotoxins; Humans; Immunoglobulins, Intravenous; Leukocidins; Linezolid; Male; Multiple Organ Failure; Oxazolidinones; Pneumonia, Bacterial; Respiratory Distress Syndrome; Staphylococcal Infections | 2009 |
Severe ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus and other pathogens: report of a case successfully managed by serial surveillance cultures of endotracheal aspirates.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bronchoalveolar Lavage; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Pneumonia, Ventilator-Associated; Respiratory Distress Syndrome; Staphylococcal Infections; Vancomycin | 2011 |
Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin.
Topics: Acetamides; Cohort Studies; Cost-Benefit Analysis; Drug Costs; Female; Hospital Costs; Humans; Intensive Care Units; Linezolid; Male; Oxazolidinones; Pneumonia, Aspiration; Pneumonia, Staphylococcal; Quality-Adjusted Life Years; Respiration, Artificial; Respiratory Distress Syndrome; United States; Vancomycin; Ventilators, Mechanical | 2004 |